ID   MCAT_HUMAN              Reviewed;         301 AA.
AC   O43772; B2R7F4; Q9UIQ2;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   15-MAR-2017, entry version 159.
DE   RecName: Full=Mitochondrial carnitine/acylcarnitine carrier protein;
DE   AltName: Full=Carnitine/acylcarnitine translocase;
DE            Short=CAC;
DE   AltName: Full=Solute carrier family 25 member 20;
GN   Name=SLC25A20; Synonyms=CAC, CACT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DISEASE.
RC   TISSUE=Liver;
RX   PubMed=9399886; DOI=10.1086/301628;
RA   Huizing M., Iacobazzi V., Ijlst L., Savelkoul P., Ruitenbeek W.,
RA   van den Heuvel L., Indiveri C., Smeitink J., Trijbels F., Wanders R.,
RA   Palmieri F.;
RT   "Cloning of the human carnitine-acylcarnitine carrier cDNA and
RT   identification of the molecular defect in a patient.";
RL   Am. J. Hum. Genet. 61:1239-1245(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9837782; DOI=10.1006/bbrc.1998.9738;
RA   Iacobazzi V., Naglieri M.A., Stanley C.A., Wanders R.J.A.,
RA   Palmieri F.;
RT   "The structure and organization of the human carnitine/acylcarnitine
RT   translocase (CACT) gene.";
RL   Biochem. Biophys. Res. Commun. 252:770-774(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   VARIANT CACTD ARG-238.
RX   PubMed=12859414; DOI=10.1034/j.1399-0004.2003.00117.x;
RA   Al-Aqeel A.I., Rashid M.S., Ruiter J.P., Ijlst L., Wanders R.J.A.;
RT   "A novel molecular defect of the carnitine acylcarnitine translocase
RT   gene in a Saudi patient.";
RL   Clin. Genet. 64:163-165(2003).
RN   [9]
RP   VARIANT CACTD ARG-238.
RX   PubMed=15057979; DOI=10.1002/ajmg.a.20573;
RA   Iacobazzi V., Pasquali M., Singh R., Matern D., Rinaldo P.,
RA   Amat di San Filippo C., Palmieri F., Longo N.;
RT   "Response to therapy in carnitine/acylcarnitine translocase (CACT)
RT   deficiency due to a novel missense mutation.";
RL   Am. J. Med. Genet. A 126:150-155(2004).
RN   [10]
RP   VARIANTS CACTD TRP-133 AND HIS-231.
RX   PubMed=15365988; DOI=10.1002/humu.20085;
RA   Iacobazzi V., Invernizzi F., Baratta S., Pons R., Chung W.,
RA   Garavaglia B., Dionisi-Vici C., Ribes A., Parini R., Huertas M.D.,
RA   Roldan S., Lauria G., Palmieri F., Taroni F.;
RT   "Molecular and functional analysis of SLC25A20 mutations causing
RT   carnitine-acylcarnitine translocase deficiency.";
RL   Hum. Mutat. 24:312-320(2004).
CC   -!- FUNCTION: Mediates the transport of acylcarnitines of different
CC       length across the mitochondrial inner membrane from the cytosol to
CC       the mitochondrial matrix for their oxidation by the mitochondrial
CC       fatty acid-oxidation pathway.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane; Multi-pass
CC       membrane protein.
CC   -!- DISEASE: Carnitine-acylcarnitine translocase deficiency (CACTD)
CC       [MIM:212138]: A rare long-chain fatty acid oxidation disorder.
CC       Metabolic consequences include hypoketotic hypoglycemia under
CC       fasting conditions, hyperammonemia, elevated creatine kinase and
CC       transaminases, dicarboxylic aciduria, very low free carnitine and
CC       abnormal acylcarnitine profile with marked elevation of the long-
CC       chain acylcarnitines. Clinical features include neurologic
CC       abnormalities, cardiomyopathy, arrhythmias, skeletal muscle
CC       damage, liver dysfunction and episodes of life-threatening coma,
CC       which eventually lead to death. Most patients become symptomatic
CC       in the neonatal period with a rapidly progressive deterioration
CC       and a high mortality rate. {ECO:0000269|PubMed:12859414,
CC       ECO:0000269|PubMed:15057979, ECO:0000269|PubMed:15365988}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y10319; CAA71367.1; -; mRNA.
DR   EMBL; Y17775; CAB55356.1; -; Genomic_DNA.
DR   EMBL; Y17776; CAB55356.1; JOINED; Genomic_DNA.
DR   EMBL; Y17777; CAB55356.1; JOINED; Genomic_DNA.
DR   EMBL; Y17778; CAB55356.1; JOINED; Genomic_DNA.
DR   EMBL; Y17779; CAB55356.1; JOINED; Genomic_DNA.
DR   EMBL; AK312962; BAG35801.1; -; mRNA.
DR   EMBL; BC001689; AAH01689.1; -; mRNA.
DR   CCDS; CCDS2779.1; -.
DR   RefSeq; NP_000378.1; NM_000387.5.
DR   UniGene; Hs.13845; -.
DR   ProteinModelPortal; O43772; -.
DR   BioGrid; 107241; 20.
DR   IntAct; O43772; 6.
DR   MINT; MINT-1370660; -.
DR   STRING; 9606.ENSP00000326305; -.
DR   BindingDB; O43772; -.
DR   ChEMBL; CHEMBL2216740; -.
DR   DrugBank; DB00583; L-Carnitine.
DR   TCDB; 2.A.29.8.3; the mitochondrial carrier (mc) family.
DR   iPTMnet; O43772; -.
DR   PhosphoSitePlus; O43772; -.
DR   BioMuta; SLC25A20; -.
DR   EPD; O43772; -.
DR   MaxQB; O43772; -.
DR   PaxDb; O43772; -.
DR   PeptideAtlas; O43772; -.
DR   PRIDE; O43772; -.
DR   TopDownProteomics; O43772; -.
DR   DNASU; 788; -.
DR   Ensembl; ENST00000319017; ENSP00000326305; ENSG00000178537.
DR   GeneID; 788; -.
DR   KEGG; hsa:788; -.
DR   UCSC; uc003cva.5; human.
DR   CTD; 788; -.
DR   DisGeNET; 788; -.
DR   GeneCards; SLC25A20; -.
DR   HGNC; HGNC:1421; SLC25A20.
DR   HPA; HPA016862; -.
DR   HPA; HPA029863; -.
DR   MalaCards; SLC25A20; -.
DR   MIM; 212138; phenotype.
DR   MIM; 613698; gene.
DR   neXtProt; NX_O43772; -.
DR   OpenTargets; ENSG00000178537; -.
DR   Orphanet; 159; Carnitine-acylcarnitine translocase deficiency.
DR   PharmGKB; PA35031; -.
DR   eggNOG; KOG0758; Eukaryota.
DR   eggNOG; ENOG410XS86; LUCA.
DR   GeneTree; ENSGT00700000104295; -.
DR   HOGENOM; HOG000168307; -.
DR   HOVERGEN; HBG003500; -.
DR   InParanoid; O43772; -.
DR   KO; K15109; -.
DR   OMA; AGKSHNE; -.
DR   OrthoDB; EOG091G0HVE; -.
DR   PhylomeDB; O43772; -.
DR   TreeFam; TF300894; -.
DR   BioCyc; MetaCyc:ENSG00000178537-MONOMER; -.
DR   Reactome; R-HSA-200425; Import of palmitoyl-CoA into the mitochondrial matrix.
DR   GenomeRNAi; 788; -.
DR   PRO; PR:O43772; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000178537; -.
DR   CleanEx; HS_SLC25A20; -.
DR   ExpressionAtlas; O43772; baseline and differential.
DR   Genevisible; O43772; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0015227; F:acyl carnitine transmembrane transporter activity; EXP:Reactome.
DR   GO; GO:0015226; F:carnitine transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005476; F:carnitine:acyl carnitine antiporter activity; IBA:GO_Central.
DR   GO; GO:0006853; P:carnitine shuttle; TAS:Reactome.
DR   GO; GO:0015879; P:carnitine transport; IBA:GO_Central.
DR   GO; GO:0006839; P:mitochondrial transport; IBA:GO_Central.
DR   Gene3D; 1.50.40.10; -; 1.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom.
DR   Pfam; PF00153; Mito_carr; 3.
DR   SUPFAM; SSF103506; SSF103506; 1.
DR   PROSITE; PS50920; SOLCAR; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Disease mutation; Membrane;
KW   Mitochondrion; Mitochondrion inner membrane; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:25944712}.
FT   CHAIN         2    301       Mitochondrial carnitine/acylcarnitine
FT                                carrier protein.
FT                                /FTId=PRO_0000090628.
FT   TOPO_DOM      2     12       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     13     31       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     32     73       Mitochondrial matrix. {ECO:0000255}.
FT   TRANSMEM     74     93       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM     94    112       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    113    131       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    132    170       Mitochondrial matrix. {ECO:0000255}.
FT   TRANSMEM    171    190       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    191    211       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    212    230       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    231    267       Mitochondrial matrix. {ECO:0000255}.
FT   TRANSMEM    268    287       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    288    301       Cytoplasmic. {ECO:0000255}.
FT   REPEAT        8     99       Solcar 1.
FT   REPEAT      108    196       Solcar 2.
FT   REPEAT      207    293       Solcar 3.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:25944712}.
FT   MOD_RES     148    148       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9Z2Z6}.
FT   MOD_RES     157    157       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9Z2Z6}.
FT   MOD_RES     170    170       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9Z2Z6}.
FT   MOD_RES     170    170       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9Z2Z6}.
FT   VARIANT     133    133       R -> W (in CACTD; dbSNP:rs748394731).
FT                                {ECO:0000269|PubMed:15365988}.
FT                                /FTId=VAR_021818.
FT   VARIANT     231    231       D -> H (in CACTD; dbSNP:rs577331691).
FT                                {ECO:0000269|PubMed:15365988}.
FT                                /FTId=VAR_021819.
FT   VARIANT     238    238       Q -> R (in CACTD; dbSNP:rs28934589).
FT                                {ECO:0000269|PubMed:12859414,
FT                                ECO:0000269|PubMed:15057979}.
FT                                /FTId=VAR_021820.
FT   CONFLICT    203    203       R -> S (in Ref. 2; CAB55356).
FT                                {ECO:0000305}.
FT   CONFLICT    240    240       A -> G (in Ref. 2; CAB55356).
FT                                {ECO:0000305}.
SQ   SEQUENCE   301 AA;  32944 MW;  AEB34E4E335102B0 CRC64;
     MADQPKPISP LKNLLAGGFG GVCLVFVGHP LDTVKVRLQT QPPSLPGQPP MYSGTFDCFR
     KTLFREGITG LYRGMAAPII GVTPMFAVCF FGFGLGKKLQ QKHPEDVLSY PQLFAAGMLS
     GVFTTGIMTP GERIKCLLQI QASSGESKYT GTLDCAKKLY QEFGIRGIYK GTVLTLMRDV
     PASGMYFMTY EWLKNIFTPE GKRVSELSAP RILVAGGIAG IFNWAVAIPP DVLKSRFQTA
     PPGKYPNGFR DVLRELIRDE GVTSLYKGFN AVMIRAFPAN AACFLGFEVA MKFLNWATPN
     L
//
